| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.9M | +0.1% | +1.1% |
| Cost of Revenue | $1.4M | +5.4% | +11.0% |
| Gross Profit | $2.5M | -2.6% | -3.7% |
| R&D Expense | $873K | +10.2% | -21.4% |
| SG&A Expense | $762K | +7.2% | -2.7% |
| Operating Income | -$426K | -149.1% | +42.8% |
| Pre-tax Income | -$427K | -427.2% | +41.1% |
| Income Tax | $5K | +0.0% | +0.0% |
| Net Income | -$432K | -402.3% | +40.8% |
| EPS (Basic) | -$0.04 | -300.0% | +60.0% |
| EPS (Diluted) | -$0.04 | -300.0% | +60.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.4M | -7.3% | -50.1% |
| Accounts Receivable | $1.4M | -12.1% | -0.1% |
| Current Assets | $3.5M | -5.9% | -26.6% |
| Total Assets | $15.3M | -2.6% | -10.0% |
| Current Liabilities | $5.2M | -0.3% | -4.8% |
| Long-term Debt | $209K | -11.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$79K | -102.6% | — |
| Capital Expenditures | $24K | +242.9% | — |
| Investing Cash Flow | -$44K | -158.8% | — |
| Financing Cash Flow | -$122K | — | — |
| Free Cash Flow | -$103K | -123.9% | — |
| -48.5% |
| Total Liabilities | $6.1M | -1.5% | -5.3% |
| Stockholders' Equity | $9.2M | -3.3% | -12.8% |